Biomotion Sciences Ordinary Shares
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for … Read more
Market Cap & Net Worth: Biomotion Sciences Ordinary Shares (SLXN)
Biomotion Sciences Ordinary Shares (NASDAQ:SLXN) has a market capitalization of $4.78 Million ($4.78 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #31592 globally and #10401 in its home market, demonstrating a -18.62% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biomotion Sciences Ordinary Shares's stock price $1.53 by its total outstanding shares 3126642 (3.13 Million).
Biomotion Sciences Ordinary Shares Market Cap History: 2021 to 2026
Biomotion Sciences Ordinary Shares's market capitalization history from 2021 to 2026. Data shows change from $30.27 Million to $4.78 Million (-31.57% CAGR).
Index Memberships
Biomotion Sciences Ordinary Shares is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.20 Trillion | 0.00% | #808 of 976 |
Weight: Biomotion Sciences Ordinary Shares's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Biomotion Sciences Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biomotion Sciences Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SLXN by Market Capitalization
Companies near Biomotion Sciences Ordinary Shares in the global market cap rankings as of March 19, 2026.
Key companies related to Biomotion Sciences Ordinary Shares by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Biomotion Sciences Ordinary Shares Historical Marketcap From 2021 to 2026
Between 2021 and today, Biomotion Sciences Ordinary Shares's market cap moved from $30.27 Million to $ 4.78 Million, with a yearly change of -31.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $4.78 Million | -20.31% |
| 2025 | $6.00 Million | -4.48% |
| 2024 | $6.28 Million | -81.47% |
| 2023 | $33.92 Million | +7.75% |
| 2022 | $31.49 Million | +4.03% |
| 2021 | $30.27 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Biomotion Sciences Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.78 Million USD |
| MoneyControl | $4.78 Million USD |
| MarketWatch | $4.78 Million USD |
| marketcap.company | $4.78 Million USD |
| Reuters | $4.78 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.